Daily voice recordings reveal early signs of asthma and COPD exacerbations, suggesting voice analysis could enhance remote ...

Light physical activity (PA) significantly improved survival in adults with chronic obstructive pulmonary disease (COPD), ...

The American Lung Association is announcing a new initiative to help people living with chronic obstructive pulmonary disease (COPD) better manage symptoms and improve quality of life. More than 16 ...

AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & ...

Combined pulmonary fibrosis and emphysema (CPFE) is a rare condition that causes both scarred lung tissue and damaged air sacs, leading to symptoms like worsening shortness of breath, cough, and ...

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long COVID ...

Medically reviewed by David Ozeri, MD Key Takeaways Inflammation helps your body heal, but if it lasts too long, it can cause ...

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.

Respiratory diseases continue to represent a major global health burden, ranking among the leading causes of morbidity and mortality. They encompass a wide ...

Mexico finished atop Group A with a perfect nine points and will face Ecuador in the Round of 32 on Tuesday at Mexico City Stadium. South Africa claimed second place with four points and advances to ...

In AstraZeneca’s third trip to Asia this year, the pharma secured ex-China rights to a dual inhibitor of PDE3 and PDE4, which in a Phase 2b study significantly improved lung function and lowered ...